BLM and Miyoshi myopathy: In our effort to identify new therapeutic targets in MM, we found that the BLM gene, which encodes the Bloom’s syndrome (BS) protein BLM, an ATP-dependent 3’-5’ DNA helicase (20–22), is associated with a poor prognostic value in MM patients.